The key IPO to watch this week is Gaudium IVF & Women Health. Its subscription window opens on February 20 and closes on February 24. The company will list on BSE and NSE on February 27, with allotment expected by February 25. Currently, there is no Grey Market Premium (GMP) for Gaudium IVF. The IPO offers 2.09 crore shares, including 1.14 crore fresh shares and 0.95 crore offer for sale. The price band is yet to be announced. The issue will allocate up to 50% to qualified institutional buyers, at least 35% to retail investors, and at least 15% to non-institutional investors. Founded in 2015, Gaudium IVF provides fertility treatments like IVF, ICSI, and IUI. It operates over 30 centers in top cities like Delhi, Mumbai, Bengaluru, and Patna, and serves international patients. The company showed solid growth with Rs 70.96 crore income and Rs 19.13 crore profit in FY25, and Rs 49.75 crore income with Rs 12.51 crore profit in H1 FY26. Meanwhile, Fractal Industries launches its SME IPO from February 16 to 18 at a price band of Rs 205-216. It will list on BSE SME platform. Next week, three companies will debut on stock exchanges. Fractal Analytics lists on February 16 after 2x subscription, boosted by strong QIB interest. Aye Finance also lists next week, backed by strong institutional support. Both Fractal Analytics and Aye Finance show negative GMP in grey markets, signaling cautious investor sentiment and subdued listing expectations. With fresh listings in healthcare and SME sectors, next week will reveal new investor appetite amid muted primary market action.